HomeBusinessEisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approvalFILE PHOTO: A sign marks a Biogen facility in Cambridge Estimated read time 1 min read FILE PHOTO: A sign marks a Biogen facility in Cambridge FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S., March 9, 2020. REUTERS/Brian Snyder
